Literature DB >> 25127701

Surgical outcomes of progressive tractional retinal detachment associated with familial exudative vitreoretinopathy.

Takahiro Yamane1, Tadashi Yokoi1, Yuri Nakayama1, Sachiko Nishina1, Noriyuki Azuma2.   

Abstract

PURPOSE: To evaluate various surgeries for treating retinal detachment (RD) associated with familial exudative vitreoretinopathy (FEVR).
DESIGN: Retrospective, interventional case series.
METHODS: The charts of 22 patients who underwent surgery were reviewed. A complete ophthalmic examination was performed including wide-field fundus images with fluorescein angiography. The primary and secondary outcomes were fundus features (vascular activity of the fibrovascular proliferation and extent of tractional RD) and visual acuity (VA), respectively.
RESULTS: Thirty-one eyes were included (12 eyes underwent scleral buckling, 1 scleral buckling and vitrectomy, 7 vitrectomy alone, and 11 lensectomy and vitrectomy). Twenty-six eyes were reattached during 1 surgery. Scleral buckling resulted in cessation of fibrovascular proliferation and retinal reattachment; only 1 of these eyes required vitrectomy. Lens-sparing vitrectomy resulted in stabilized fibrovascular proliferation and retinal reattachment. Vitrectomy with lensectomy did not achieve retinal reattachment in 4 eyes. Fibrovascular proliferation has a rich vascular component in patients younger than 3 years, and collagen fibers were present mainly with more advanced age. The postoperative VA improved in 5 of 8 eyes examined, was unchanged in 1 eye, and decreased in 2 eyes with macular involvement.
CONCLUSIONS: FEVR-induced RDs are highly variable and require careful preoperative evaluation to determine the best surgical procedure. Vitrectomy with release of posterior traction is essential in younger patients with vascularly active fibrovascular proliferation, whereas scleral buckling may be important for cases with peripheral traction anterior to the equator. In all cases, peripheral thermal treatment applied to all ischemic areas contributed to reduced peripheral neovascularization.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25127701     DOI: 10.1016/j.ajo.2014.08.009

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  13 in total

1.  25-gauge lens-sparing vitrectomy with dissection of retrolental adhesions on the peripheral retina for familial exudative vitreoretinopathy in infants.

Authors:  Jin Ma; Yin Hu; Lin Lu; Xiaohu Ding
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-16       Impact factor: 3.117

2.  Pharmacologic Activation of Wnt Signaling by Lithium Normalizes Retinal Vasculature in a Murine Model of Familial Exudative Vitreoretinopathy.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Ye Sun; Yan Gong; Tara L Favazza; Peyton C Morss; Nicholas J Saba; Thomas W Fredrick; Xi He; James D Akula; Jing Chen
Journal:  Am J Pathol       Date:  2016-08-12       Impact factor: 4.307

3.  RETINAL DETACHMENT SURGERY IN A PEDIATRIC POPULATION: Visual and Anatomic Outcomes.

Authors:  Sarah P Read; Hassan A Aziz; Ajay Kuriyan; Nikisha Kothari; Janet L Davis; William E Smiddy; Harry W Flynn; Timothy G Murray; Audina Berrocal
Journal:  Retina       Date:  2018-07       Impact factor: 4.256

4.  LONGITUDINAL CHANGES IN THE OPTIC NERVE HEAD AND RETINA OVER TIME IN VERY YOUNG CHILDREN WITH FAMILIAL EXUDATIVE VITREORETINOPATHY.

Authors:  Jonghyun Lee; Mays A El-Dairi; Du Tran-Viet; Shwetha Mangalesh; Alexandria Dandridge; Kim Jiramongkolchai; Christian Viehland; Cynthia A Toth
Journal:  Retina       Date:  2019-01       Impact factor: 4.256

5.  Surgical treatments for fibrous tissue extending to the posterior retina in eyes with familial exudative vitreoretinopathy.

Authors:  Mari Takahashi; Tadashi Yokoi; Satoshi Katagiri; Tomoyo Yoshida-Uemura; Sachiko Nishina; Noriyuki Azuma
Journal:  Jpn J Ophthalmol       Date:  2017-11-03       Impact factor: 2.447

6.  Analysis of Predisposing Clinical Features for Worsening Traction After Treatment of Familial Exudative Vitreoretinopathy in Children.

Authors:  G Baker Hubbard; Alexa L Li
Journal:  Am J Ophthalmol       Date:  2020-07-21       Impact factor: 5.258

7.  Early vitrectomy to reverse macular dragging in a one-month-old boy with familial exudative vitreoretinopathy.

Authors:  Akiko Iwata; Shunji Kusaka; Mayumi Ishimaru; Hiroyuki Kondo; Kazuki Kuniyoshi
Journal:  Am J Ophthalmol Case Rep       Date:  2019-06-11

8.  Diagnosis of complicated FEVR preoperatively and intra-/post-operatively: characteristics and risk factors for diagnostic timing.

Authors:  Fengjie Xia; Jiao Lyu; Ping Fei; Peiquan Zhao
Journal:  BMC Ophthalmol       Date:  2019-06-08       Impact factor: 2.209

9.  INTRAVITREAL RANIBIZUMAB TREATMENT FOR ADVANCED FAMILIAL EXUDATIVE VITREORETINOPATHY WITH HIGH VASCULAR ACTIVITY.

Authors:  Jiao Lyu; Qi Zhang; Yu Xu; Xiang Zhang; Ping Fei; Peiquan Zhao
Journal:  Retina       Date:  2021-09-01       Impact factor: 4.256

10.  Familial exudative vitreoretinopathy complicated with full thickness macular hole: A case report.

Authors:  Daisaku Kimura; Takatoshi Kobayashi; Eri Maruyama; Shou Oosuka; Ryohsuke Kohmoto; Masanori Fukumoto; Takaki Sato; Teruyo Kida; Tsunehiko Ikeda
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.